Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-Randomized, Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM System to Transcranial Doppler as an Aid to Diagnosing Vasospasm

NCT01595802 is registered in ClinicalTrials.gov with Jan Medical, Inc. as lead sponsor.

NCT NCT01595802
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01595802 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-Randomized, Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM System to Transcranial Doppler as an Aid to Diagnosing Vasospasm
Lead sponsor
Jan Medical, Inc.
Phase
Observational
Overall status
Completed
Start date
January 31, 2012
Completion date
July 31, 2015
Enrollment
92 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cerebral vasospasm